Dupont Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-33,857
| Closed | -$484K | – | 1037 |
|
|
2022
Q4 | $484K | Buy |
33,857
+3,988
| +13% | +$57.1K | 0.02% | 574 |
|
|
2022
Q3 | $763K | Buy |
29,869
+2,052
| +7% | +$52.4K | 0.05% | 492 |
|
|
2022
Q2 | $790K | Buy |
27,817
+2,354
| +9% | +$66.9K | 0.04% | 554 |
|
|
2022
Q1 | $898K | Sell |
25,463
-16,506
| -39% | -$582K | 0.04% | 565 |
|
|
2021
Q4 | $1.76M | Buy |
41,969
+40,113
| +2,161% | +$1.68M | 0.06% | 314 |
|
|
2021
Q3 | $91K | Sell |
1,856
-9,518
| -84% | -$467K | ﹤0.01% | 1354 |
|
|
2021
Q2 | $475K | Buy |
+11,374
| New | +$475K | 0.01% | 1029 |
|